Cargando…

Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2

The activation of nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase, Sirt1, after the administration of nicotinamide mononucleotide (NMN) suppresses many diseases. However, the role of NMN and Sirt1 in focal glomerulosclerosis (FSGS) has not yet been elucidated. This study aimed to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasegawa, Kazuhiro, Sakamaki, Yusuke, Tamaki, Masanori, Wakino, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374671/ https://www.ncbi.nlm.nih.gov/pubmed/35962139 http://dx.doi.org/10.1038/s41598-022-18147-2

Ejemplares similares

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health
por: Alegre, Gabriela Fabiana Soares, et al.
Publicado: (2023)

A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
por: Di Stefano, M, et al.
Publicado: (2015)

β-nicotinamide mononucleotide (NMN) production in Escherichia coli
por: Marinescu, George Cătălin, et al.
Publicado: (2018)

Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise
por: Uddin, Golam Mezbah, et al.
Publicado: (2017)

Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns
por: Nadeeshani, Harshani, et al.
Publicado: (2021)

Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice
por: Uddin, Golam M., et al.
Publicado: (2016)

Size Exclusion Chromatography Method for Purification of Nicotinamide Mononucleotide (NMN) from Bacterial Cells
por: Marinescu, George Cătălin, et al.
Publicado: (2018)

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD
por: Sverkeli, Lars Jansen, et al.
Publicado: (2021)

Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers
por: Uddin, Golam M., et al.
Publicado: (2020)

Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment
por: Chen, Xiaohong, et al.
Publicado: (2020)

Nicotinamide mononucleotide (NMN) alleviates the poly(I:C)-induced inflammatory response in human primary cell cultures
por: Sano, Hitomi, et al.
Publicado: (2023)

β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice
por: Zhou, Xianrong, et al.
Publicado: (2021)

Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial
por: Gao, Xiangyang, et al.
Publicado: (2023)

Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice
por: Tarantini, Stefano, et al.
Publicado: (2019)

Nicotinamide Mononucleotide, an Intermediate of NAD(+) Synthesis, Protects the Heart from Ischemia and Reperfusion
por: Yamamoto, Takanobu, et al.
Publicado: (2014)

Nicotinamide mononucleotide ameliorates senescence in alveolar epithelial cells
por: Fang, Tingting, et al.
Publicado: (2021)

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
por: Hong, Weiqi, et al.
Publicado: (2020)

The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions
por: Fortunato, Carlo, et al.
Publicado: (2021)

Nicotinamide mononucleotide adenylyltransferase uses its NAD(+) substrate-binding site to chaperone phosphorylated Tau
por: Ma, Xiaojuan, et al.
Publicado: (2020)

Safety Evaluation for Restorin® NMN, a NAD+ Precursor
por: Turner, John, et al.
Publicado: (2021)

Antioxidant effect of nicotinamide mononucleotide in tendinopathy
por: Yamaura, Kohei, et al.
Publicado: (2022)

Nicotinamide Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium Iodate in RPE
por: Ren, Chengda, et al.
Publicado: (2022)

Novel tubular–glomerular interplay in diabetic kidney disease mediated by sirtuin 1, nicotinamide mononucleotide, and nicotinamide adenine dinucleotide Oshima Award Address 2017
por: Hasegawa, Kazuhiro
Publicado: (2019)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Differences in Extracellular NAD(+) and NMN Metabolism on the Surface of Vascular Endothelial Cells
por: Jablonska, Patrycja, et al.
Publicado: (2022)

Identification of the nicotinamide mononucleotide adenylyltransferase of Trypanosoma cruzi
por: Niño, Carlos H, et al.
Publicado: (2015)

Correction: Antioxidant effect of nicotinamide mononucleotide in tendinopathy
por: Yamaura, Kohei, et al.
Publicado: (2022)

Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair.
por: Boulton, S., et al.
Publicado: (1997)

Nicotinamide Phosphoribosyltransferase/Visfatin Does Not Catalyze Nicotinamide Mononucleotide Formation in Blood Plasma
por: Hara, Nobumasa, et al.
Publicado: (2011)

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Ratajczak, Joanna, et al.
Publicado: (2016)

Metabolic engineering of Escherichia coli for biosynthesis of β‐nicotinamide mononucleotide from nicotinamide
por: Liu, Yang, et al.
Publicado: (2021)

The NAD(+) precursor NMN activates dSarm to trigger axon degeneration in Drosophila
por: Llobet Rosell, Arnau, et al.
Publicado: (2022)

Nicotinamide Mononucleotide Supplementation Improves Mitochondrial Dysfunction and Rescues Cellular Senescence by NAD(+)/Sirt3 Pathway in Mesenchymal Stem Cells
por: Wang, Huan, et al.
Publicado: (2022)

Nicotinamide mononucleotide attenuates HIF-1α activation and fibrosis in hypoxic adipose tissue via NAD(+)/SIRT1 axis
por: Wu, Keke, et al.
Publicado: (2023)

β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice
por: Li, Hui-ru, et al.
Publicado: (2023)

Nicotinamide mononucleotide (NMN) protects bEnd.3 cells against H(2)O(2)‐induced damage via NAMPT and the NF‐κB p65 signalling pathway
por: Deng, Xiujun, et al.
Publicado: (2021)

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
por: Yi, Lin, et al.
Publicado: (2022)

Nicotinamide mononucleotide production by fructophilic lactic acid bacteria
por: Sugiyama, Kazane, et al.
Publicado: (2021)

Nicotinamide mononucleotide improves spermatogenic function in streptozotocin-induced diabetic mice via modulating the glycolysis pathway: Nicotinamide mononucleotide improves spermatogenic function
por: Ma, Duo, et al.
Publicado: (2022)

Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
por: Ramanathan, Chidambaram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4kbj6nvanmh1agnetrh6hphmu